Find trials
Search tips

Elisa Eosinophil Peroxidase Assay vs. Validation of a Lateral Flow in Nasal Samples

Overview

About this study

The purpose of this study is to compare lateral flow assay eosinophil peroxidase (LFA-EPX) with ELISA-EPX

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Asthma participants

  • Provider-diagnosed asthma.
  • 18 years or older.

Healthy control participants

  • Age matched, must be within 20 years of current mean of recruited  asthma participants.

Exclusion Critieria:

Asthma participants

  • COPD by history.
  • Bronchiectasis by history.

Healthy control participants

  • Any eosinophil disorder by history.
  • Asthma by history.
  • Rhinitis or sinusitis by history.
  • Upper respiratory infection in the past 2 weeks.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/5/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Matthew Rank, M.D.

Open for enrollment

Contact information:

Griffith Stratford

(480) 301-6198

Stratford.Griffith@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20582564

Mayo Clinic Footer